USA: Days after Pfizer admitted a safety audit could wipe billions off their stock market valuation, Moderna CEO Stéphane Bancel dumped hundreds of millions of dollars in stock and deleted his Twitter account.
Nothing to see here, folks. Not suspicious at all.
CEO Recent Trades:
- CEO Stephane Bancel sold 10,000 shares of MRNA stock on 02/11/2021 at the average price of $178.29. The price of the stock has increased by 3.06% since.
- CEO Stephane Bancel sold 9,000 shares of MRNA stock on 02/10/2021 at the average price of $182.74. The price of the stock has increased by 0.55% since.
- CEO Stephane Bancel sold 11,046 shares of MRNA stock on 02/05/2021 at the average price of $174.61. The price of the stock has increased by 5.23% since.
- CEO Stephane Bancel sold 19,000 shares of MRNA stock on 02/04/2021 at the average price of $161.73. The price of the stock has increased by 13.61% since.
- CEO Stephane Bancel sold 11,046 shares of MRNA stock on 01/29/2021 at the average price of $173.25. The price of the stock has increased by 6.05% since.
The Moderna CEO’s strange moves came shortly after a former Blackrock executive began investigating the death statistics from insurance companies and funeral homes.
Edward Dowd is a former hedge fund manager who started digging into death statistics from insurance companies and funeral homes:
He also started accusing Pfizer and Moderna of fraud in the vaccine clinical trials.
Then the Moderna CEO deleted his twitter account 2 days ago:
by Baxter Dmitry
Join: 👉 https://t.me/acnewspatriots
The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of AC.NEWS
Disclaimer: This article may contain statements that reflect the opinion of the author. The contents of this article are of sole responsibility of the author(s). AC.News will not be responsible for any inaccurate or incorrect statement in this article www.ac.news websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner. Reprinting this article: Non-commercial use OK. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Discussion about this post